Primary prevention with statins based on age and risk
Mortensen MB, Falk E
The Lancet · 2019
This meta-analysis evaluates the intervention under study in relation to the primary clinical outcome. Includes 183,460 participants. Evidence level: IIa.
循证研究：他汀一级预防的年龄和风险分层
Key facts at a glance
- DOI
- 10.1016/S0140-6736(19)30883-0
- PMID
- 30341046
- Journal
- The Lancet
- Year
- 2019
- Study type
- meta-analysis
- Evidence level
- IIa
- Sample size
- 183460
- Intervention
- 心血管风险评估
- Primary outcome
- ASCVD事件发生率
- Open access
- false
Study Overview
This meta-analysis enrolled 183,460 participants and examined the primary clinical outcome.
Key Findings
Results regarding the primary clinical outcome are presented.
Clinical Conclusions
See original publication for detailed findings. Evidence level: IIa.
Abstract
"This meta-analysis enrolled 183,460 participants, investigating the effects of 心血管风险评估 on ASCVD事件发生率.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed October 18, 2026. · Read our editorial policy